CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
29 hedge funds and large institutions have $318K invested in COSCIENS Biopharma Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
79% less call options, than puts
Call options by funds: $44K | Put options by funds: $209K
Holders
29
Holding in Top 10
–
Calls
$44K
Puts
$209K
Top Buyers
| 1 | +$48.1K | |
| 2 | +$35K | |
| 3 | +$20K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$8K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$7.46K |
Top Sellers
| 1 | -$62K | |
| 2 | -$16.2K | |
| 3 | -$5.6K | |
| 4 |
Two Sigma Advisers
New York
|
-$4.36K |
| 5 |
JPMorgan Chase & Co
New York
|
-$2.54K |